MSFT Research Update — June 20, 2026

Updated Thesis

Microsoft Corporation is a leading global technology company specializing in cloud computing, productivity software, and enterprise platforms. The company benefits from a very strong and widening competitive moat supported by scale, switching costs, an integrated ecosystem, and disciplined capital allocation including large buybacks and dividends. Its business quality is high, demonstrated by a 33.1% return on equity, strong revenue growth of 18.3% and earnings growth of 23.1% in the most recent quarter, and robust margins with a 68.3% gross margin and 39.3% net margin.

The investment grade as of this refresh is A — high business quality. High-tier business, cheap valuation with 45% upside to $550.13 fair value

Key Metrics at a Glance

Current price: $379.40

These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.

Our 12–18 Month Outlook

Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Microsoft Corporation remains in our covered universe with a high-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.

Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.

[View full MSFT research →](/stocks/MSFT)